Remission in asthma.
Curr Opin Pulm Med
; 30(3): 325-329, 2024 05 01.
Article
en En
| MEDLINE
| ID: mdl-38441430
ABSTRACT
PURPOSE OF REVIEW To review the current concepts of remission in asthma. RECENT FINDINGS:
Until 2023, asthma guidelines have been promoting the concept of disease control, recommending the step-wise addition of drugs until the best possible disease control is achieved. With the advent of highly effective, anti-inflammatory disease-modifying antiasthmatic drugs (DMAADs), treatment goals of asthma have changed. Several national guidelines have now announced remission as a general treatment goal in asthma. Currently, all guidelines agree that asthma remission is defined by the presence of at least three characteristics over a period of at least one 1âyear absence of exacerbations, no systemic corticosteroid use for the treatment of asthma and minimal asthma-related symptoms. In the future, a generally accepted, evidence-based and easy-to-use definition of remission will be needed for daily clinical practice. It is clear, however, that precise phenotyping (including measurement of biomarkers) is an essential prerequisite to achieve clinical remission in each individual patient.SUMMARY:
Remission has been included as the treatment goal in asthma in several national guidelines, reflecting the paradigm shift in asthma, from short-term symptom control to long-term symptom prevention. An international consensus on the criteria for asthma remission is expected in the near future.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Asma
/
Antiasmáticos
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article